4-[2-(Benzylsulfanyl)thieno[3,2-d]pyrimidin-4-yl]morpholine

Catalog No. :
ACFZSW906
CAS No. :
478067-42-4
Molecular Formula :
C17H17N3OS2
Molecular Weight :
343.48

IUPAC Name:4-(2-(benzylthio)thieno[3,2-d]pyrimidin-4-yl)morpholine

4-[2-(Benzylsulfanyl)thieno[3,2-d]pyrimidin-4-yl]morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[2-(Benzylsulfanyl)thieno[3,2-d]pyrimidin-4-yl]morpholine
IUPAC Name4-(2-(benzylthio)thieno[3,2-d]pyrimidin-4-yl)morpholine
MDL No.MFCD02082596
Molecular FormulaC17H17N3OS2
Molecular Weight343.48
SMILESN1(C2=C3C(C=CS3)=NC(SCC4=CC=CC=C4)=N2)CCOCC1
InChI KeyGKMOTHISHLQILT-UHFFFAOYSA-N
SynonymBENZYL 4-MORPHOLINOTHIENO[3,2-D]PYRIMIDIN-2-YL SULFIDE;2-(BENZYLSULFANYL)-4-MORPHOLINOTHIENO[3,2-D]PYRIMIDINE;4-[2-(benzylsulfanyl)thieno[3,2-d]pyrimidin-4-yl]morpholine;Thieno[3,2-d]pyrimidine, 4-(4-morpholinyl)-2-[(phenylmethyl)thio]-
CAS No.478067-42-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFZSW906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRMZL504 route compound structure diagram
    ACRMZL50416234-15-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZSW906 route product structure diagram
    ACFZSW906478067-42-4
Inquiry

2. ACFZSW906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZSW906 route product structure diagram
    ACFZSW906478067-42-4
Inquiry

Comments (0)